Records containing: Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-06-11An Open-Label, Randomized, 2 Way Crossover, Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
-
CLINICAL_TRIALS study record update · 2014-06-10The Effects of Mixed Herbs on Blood Glucose and Lipid Profile of Patients With Established Type II Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-06-05A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of TA-7284 as Monotherapy in the Treatment of Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-06-05A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Ranging Study in Subjects With Type 2 Diabetes Mellitus to Evaluate the Efficacy, Safety, and Tolerability of Orally-Administered SGLT2 Inhibitor TA-7284
-
CLINICAL_TRIALS study record update · 2014-06-05A 6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus With a 6 Month Safety Extension Period
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-06-03Qualitative and Quantitative Characterization of HDL in T2D After Fenofibrate or Niacin Treatment in Spanish Population
-
CLINICAL_TRIALS study record update · 2014-05-30An Open-label Study to Assess the Safety and Tolerability of MK-0431D for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy
-
CLINICAL_TRIALS study record update · 2014-05-23CSP #465D - Markers And Mechanisms of Vascular Disease in Type II Diabetes
-
CLINICAL_TRIALS study record update · 2014-05-23CSP #465C - Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal
-
CLINICAL_TRIALS study record update · 2014-05-23A Randomized, Double-blind, Placebo Controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Paediatric (10 - 17 Years Old) and Adult Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2014-05-19Multicenter, Open, Non-randomized 6 Months Study to Evaluate Efficacy and Safety Insuman® Basal, Insuman® Comb 25, Insuman® Rapid in Insulin-naÏve Patients With T2DM Who Received Baseline Education Course in the Diabetes School.
-
CLINICAL_TRIALS study record update · 2014-05-14A Multicenter, Randomized, Double-blind, Double Dummy, Active-controlled, Therapeutic Confirmatory Trial(Phase 3) to Evaluate the Efficacy and Safety of CWP-0403 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 DM Insufficiently Controlled With Metformin Alone
-
CLINICAL_TRIALS study record update · 2014-05-14A Two-Cohort, Single- and Repeat Dose Study to Examine the Pharmacokinetics, Tolerability, and Safety of Ready to Use Exenatide Once Weekly in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-05-08A Phase III Study of MP-513 in Combination With Sulfonylurea in Japanese Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-05-08A Multinational, Open Label, Non Comparative, 24-week Study to Evaluate the Blood Glucose Lowering Efficacy and Safety of a Fixed Dose Combination of Glimepiride and Metformin in Patients With Inadequately Controlled Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2014-05-08A Multicenter, Randomized, Open-label, 2-arm Parallel Group, 20-week Study Comparing the Efficacy and Safety of Fixed-dose Combination of 1 mg Glimepiride and 250 mg Metformin (AMARYL M 1/250 mg) Versus Glimepiride (AMARYL®) in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin.
-
CLINICAL_TRIALS study record update · 2014-05-07Evaluation of the Educational Program of Diabetes Mellitus: Focus on Empowerment
-
CLINICAL_TRIALS study record update · 2014-05-05Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes
-
CLINICAL_TRIALS study record update · 2014-05-02Continuous Glucose Monitoring in Subjects With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2014-05-02A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
-
CLINICAL_TRIALS study record update · 2014-04-28A Clinical Pharmacology Study of Multiple Doses of TA-7284 in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-04-28An Open-Label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of TA-7284 in Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2014-04-28Exenatide and Postprandial Endothelial Dysfunction: Effects and Mechanisms
-
CLINICAL_TRIALS study record update · 2014-04-28A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy and Acarbose Monotherapy
-
CLINICAL_TRIALS study record update · 2014-04-24Southern Danish Hypertension and Diabetes Study (SDHDS) With Amiloride